危重肝硬化患者死亡预测因素:MELD评分是否足够?
该回顾性研究纳入2011至2014年ICU收治的276例肝硬化患者,比较存活者与死亡者的临床特征。ICU入院时MELD评分预测能力较低(c-statistic 0.73),多因素分析显示MELD评分、机械通气、血管加压药和连续肾脏替代治疗是独立预测因素,联合模型预测准确性提高(c-statistic 0.87)。
要点
- ICU危重肝硬化患者中MELD评分单独预测死亡准确性有限(c-statistic 0.73)。
- 机械通气、血管加压药和连续肾脏替代治疗是独立死亡预测因素。
- 包含器官支持变量的联合模型预测准确性更高(c-statistic 0.87)。
核心结论
- MELD评分在危重肝硬化患者中预测准确性相对较差,可能不是ICU人群预后的最佳指标。
- 纳入机械通气、血管加压药和连续肾脏替代治疗等器官支持变量后,模型预测准确性显著提高。
研究设计与样本
- 回顾性综述,纳入2011年1月至2014年12月期间入住ICU的肝硬化患者,共276例符合标准。
- 比较存活者(153例)与死亡者(123例)的人口学特征、入院MELD评分及临床危险因素。
- 采用多因素回归识别独立预测因素,并评估模型预测准确性。
主要发现
- 存活者与死亡者人口学特征相似。
- 死亡者MELD评分、胃肠道出血、感染、机械通气、脑病、血管加压药、透析、肾脏替代治疗、血制品需求及ICU住院时间均增加。
- MELD评分预测能力较低(c-statistic 0.73)。
- 多因素分析显示MELD评分(AOR=1.05)、机械通气(AOR=4.55)、血管加压药(AOR=3.87)和连续肾脏替代治疗(AOR=2.43)为独立死亡预测因素。
- 联合模型预测准确性更高(c-statistic 0.87)。
临床怎么用
- 在ICU危重肝硬化患者中,不应仅依赖MELD评分评估死亡风险。
- 应结合机械通气、血管加压药和连续肾脏替代治疗等器官支持指标进行综合预后判断。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
- 单中心研究,结果外推需谨慎。
- 样本量有限,未报告模型校准度等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Critically ill cirrhotics require liver transplantation urgently, but are at high risk for perioperative mortality. The Model for End-stage Liver Disease (MELD) score, recently updated to incorporate serum sodium, estimates survival probability in patients with cirrhosis, but needs additional evaluation in the critically ill. The purpose of this study was to evaluate the predictive power of ICU admission MELD scores and identify clinical risk factors associated with increased mortality. STUDY DESIGN: This was a retrospective review of cirrhotic patients admitted to the ICU between January 2011 and December 2014. Patients who were discharged or underwent transplantation (survivors) were compared with those who died (nonsurvivors). Demographic characteristics, admission MELD scores, and clinical risk factors were recorded. Multivariate regression was used to identify independent predictors of mortality, and measures of model performance were assessed to determine predictive accuracy. RESULTS: Of 276 patients who met inclusion criteria, 153 were considered survivors and 123 were nonsurvivors. Survivor and nonsurvivor cohorts had similar demographic characteristics. Nonsurvivors had increased MELD, gastrointestinal bleeding, infection, mechanical ventilation, encephalopathy, vasopressors, dialysis, renal replacement therapy, requirement of blood products, and ICU length of stay. The MELD demonstrated low predictive power (c-statistic 0.73). Multivariate analysis identified MELD score (adjusted odds ratio [AOR] = 1.05), mechanical ventilation (AOR = 4.55), vasopressors (AOR = 3.87), and continuous renal replacement therapy (AOR = 2.43) as independent predictors of mortality, with stronger predictive accuracy (c-statistic 0.87). CONCLUSIONS: The MELD demonstrated relatively poor predictive accuracy in critically ill patients with cirrhosis and might not be the best indicator for prognosis in the ICU population. Prognostic accuracy is significantly improved when variables indicating organ support (mechanical ventilation, vasopressors, and continuous renal replacement therapy) are included in the model.
引用
- Annamalai A, Harada MY, Chen M, et al. Predictors of Mortality in the Critically Ill Cirrhotic Patient: Is the Model for End-Stage Liver Disease Enough? J Am Coll Surg. 2016. PMID: 27887981. doi:10.1016/j.jamcollsurg.2016.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。